too young!
too young!
Sex: F
Data Quality: 0 stars
ALS: 3 yrs
Bi-Pap Wheelchair Feeding tube
Bulbar: mild
Arms: severe
Chest: moderate
Legs: severe
too young!
Female, 40 years
AZ, United States
Primary Condition
ALS
First symptom
May 2007
Diagnosis
Dec 2007
Deceased
Mar 29, 2011
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

too young!'s Namenda is for:

  • ALS

too young! has not reported any side effects for Namenda.

too young!'s Namenda History (Ongoing)
Namenda (memantine)
too young! has not added a dosage.
Evaluations
Date Dosage ALS (Amyotrophic Lateral Sclerosis) Efficacy Side Effects Adherence Burden
Nov 07, 2009   Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Date
Nov 07, 2009
Advice & Tips
has slowed progression and significantly decreased my shortness of breath through out the day, which in turn has increased my energy level. best med yet
Cost
$25-49 monthly

About Namenda (Prescription Drug)

Namenda is a brand name for the drug Memantine, the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. Namenda is a brand name owned by Forest pharmaceuticals. Read more...Click to read more below

Learn more about Namenda in our Namenda Community Report.